ThermoGenesis Holdings, Inc.

Equities

THMO

US88362L2097

Office Equipment

Market Closed - OTC Markets 03:15:58 2024-07-12 pm EDT 5-day change 1st Jan Change
0.1511 USD +16.23% Intraday chart for ThermoGenesis Holdings, Inc. -6.73% -74.86%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
ThermoGenesis Holdings, Inc. Receives A Notice of Default from Boyalife Group, Inc CI
ThermoGenesis Holdings, Inc. Announces Board and Committee Resignations CI
ThermoGenesis Holdings, Inc.(NasdaqCM:THMO) dropped from S&P TMI Index CI
ThermoGenesis Holdings, Inc.(OTCPK:THMO) dropped from NASDAQ Composite Index CI
Wall Street Set to Open Higher Wednesday as Key Inflation Data Lower Than Expected MT
US Futures Slightly Higher Ahead of Fed's Rate Decision, Key Inflation Data MT
Top Premarket Decliners MT
ThermoGenesis Corp. Enters into A Manufacture and Supply Agreement with CBR Systems, Inc CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
North American Morning Briefing : Traders Await -2- DJ
North American Morning Briefing : Powell Awaited -2- DJ
Thermogenesis Holdings, Inc. Announces Resignation of Haihong Zhu, Chief Operating Officer and A Director from the Board CI
ThermoGenesis Files $30 Million Mixed Shelf MT
Transcript : ThermoGenesis Holdings, Inc., Q3 2023 Earnings Call, Nov 13, 2023
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ThermoGenesis Holdings, Inc. to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento CI
ThermoGenesis Holdings, Inc. Announces Management Changes CI
Transcript : ThermoGenesis Holdings, Inc., Q2 2023 Earnings Call, Aug 10, 2023
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
ThermoGenesis Holdings, Inc. announced that it has received $1 million in funding CI
ThermoGenesis Holdings, Inc. Announces Board Appointments CI
Top Premarket Gainers MT
North American Morning Briefing : Retail Sales, -2- DJ
ThermoGenesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chart ThermoGenesis Holdings, Inc.
More charts
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.
More about the company